… ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference … announced details about upcoming presentations and an investor & analyst event at the North American Cystic …
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Company expects up to four clinical data readouts in 2025 and 2026 across multi
… program to enter the clinic Company to host virtual Investor and Analyst Event in December to highlight translational data and … diseases. ProQR will hold a virtual Analyst and InvestorEvent in December to highlight translational …
